Overview Dividends

(MDLZ) Mondelez International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6092071058

Biscuits, Chocolate, Candy, Cheese, Beverages

MDLZ EPS (Earnings per Share)

EPS Growth (3Y CAGR): 0.00%
EPS Trend (3Y Correlation): -27.7%

MDLZ Revenue

Revenue Growth (3Y CAGR): 4.23%
Revenue Trend (3Y Correlation): 50.9%

Description: MDLZ Mondelez International September 26, 2025

Mondelez International (NASDAQ: MDLZ) is a global snack-food company that sells biscuits, crackers, snack bars, cakes, chocolates, gums, candies, cheese, grocery items and powdered beverages across North America, Latin America, Europe, Asia, the Middle East and Africa.

Its core brands include Oreo, Ritz, LU, CLIF Bar, Tate’s Bake Shop, Cadbury Dairy Milk, Milka and Toblerone, reaching consumers through supermarkets, club stores, convenience outlets, gasoline stations, drug stores, mass-merchandisers and e-retail platforms, with a mix of direct-store-delivery, warehouse distribution and third-party logistics.

In FY 2023 the company reported net revenue of $30.2 billion, with a 12 % organic growth rate in emerging markets driven by rising disposable income and urbanisation, while U.S. sales were flat due to inflation-squeezed consumer spending. The snack sector’s resilience to economic cycles and its shift toward “better-for-you” products remain key macro drivers.

Mondelez’s e-commerce share grew to roughly 8 % of total sales in 2023, reflecting accelerated digital adoption post-COVID-19, and the firm is investing in direct-to-consumer sites and data-analytics capabilities to capture higher-margin online demand.

For a deeper quantitative breakdown of MDLZ’s valuation metrics, the ValueRay platform offers a granular, data-driven view worth exploring.

MDLZ Stock Overview

Market Cap in USD	73,099m
Sub-Industry	Packaged Foods & Meats
IPO / Inception	2001-06-13

MDLZ Stock Ratings

Growth Rating	3.57%
Fundamental	58.1%
Dividend Rating	69.2%
Return 12m vs S&P 500	-29.5%
Analyst Rating	4.07 of 5

MDLZ Dividends

Dividend Yield 12m	3.41%
Yield on Cost 5y	3.86%
Annual Growth 5y	10.51%
Payout Consistency	96.7%
Payout Ratio	67.0%

MDLZ Growth Ratios

Growth Correlation 3m	-9.5%
Growth Correlation 12m	13.9%
Growth Correlation 5y	68.8%
CAGR 5y	-1.79%
CAGR/Max DD 3y (Calmar Ratio)	-0.07
CAGR/Mean DD 3y (Pain Ratio)	-0.20
Sharpe Ratio 12m	-0.72
Alpha	-27.13
Beta	0.457
Volatility	23.70%
Current Volume	12540.2k
Average Volume 20d	7063.7k
Stop Loss	54.3 (-3.2%)
Signal	-0.26

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (3.53b TTM) > 0 and > 6% of Revenue (6% = 2.26b TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA -1.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -22.22% (prev -21.78%; Δ -0.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.05 (>3.0%) and CFO 3.58b > Net Income 3.53b (YES >=105%, WARN >=100%)

Net Debt (20.57b) to EBITDA (5.47b) ratio: 3.76 <= 3.0 (WARN <= 3.5)

Current Ratio 0.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.30b) change vs 12m ago -3.01% (target <= -2.0% for YES)

Gross Margin 30.99% (prev 38.77%; Δ -7.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 52.45% (prev 50.08%; Δ 2.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 9.45 (EBITDA TTM 5.47b / Interest Expense TTM 437.0m) >= 6 (WARN >= 3)

Altman Z'' 1.86

(A) -0.12 = (Total Current Assets 13.15b - Total Current Liabilities 21.51b) / Total Assets 71.36b

(B) 0.51 = Retained Earnings (Balance) 36.39b / Total Assets 71.36b

(D) 0.55 = Book Value of Equity 24.93b / Total Liabilities 45.13b

Total Rating: 1.86 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 58.12

1. Piotroski 5.0pt = 0.0

2. FCF Yield 2.44% = 1.22

3. FCF Margin 6.08% = 1.52

4. Debt/Equity 0.84 = 2.16

5. Debt/Ebitda 3.76 = -2.46

6. ROIC - WACC (= 1.69)% = 2.11

7. RoE 13.44% = 1.12

8. Rev. Trend 50.90% = 3.82

9. EPS Trend -27.65% = -1.38

What is the price of MDLZ shares?

As of November 05, 2025, the stock is trading at USD 56.08 with a total of 12,540,188 shares traded.
Over the past week, the price has changed by -6.86%, over one month by -9.23%, over three months by -11.02% and over the past year by -15.48%.

Is Mondelez International a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Mondelez International is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 58.12 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MDLZ is around 52.69 USD . This means that MDLZ is currently overvalued and has a potential downside of -6.04%.

Is MDLZ a buy, sell or hold?

Mondelez International has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy MDLZ.

Strong Buy: 11
Buy: 8
Hold: 9
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the MDLZ price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	69.4	23.7%
Analysts Target Price	69.4	23.7%
ValueRay Target Price	57.4	2.4%

MDLZ Fundamental Data Overview November 05, 2025

Market Cap USD = 73.10b (73.10b USD * 1.0 USD.USD)
P/E Trailing = 21.2172
P/E Forward = 18.622
P/S = 1.9418
P/B = 3.052
P/EG = 4.7592
Beta = 0.457
Revenue TTM = 37.65b USD
EBIT TTM = 4.13b USD
EBITDA TTM = 5.47b USD
Long Term Debt = 15.66b USD (from longTermDebt, last fiscal year)
Short Term Debt = 4.19b USD (from shortTermDebt, last quarter)
Debt = 21.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.57b USD (from netDebt column, last quarter)
Enterprise Value = 93.66b USD (73.10b + Debt 21.93b - CCE 1.37b)
Interest Coverage Ratio = 9.45 (Ebit TTM 4.13b / Interest Expense TTM 437.0m)
FCF Yield = 2.44% (FCF TTM 2.29b / Enterprise Value 93.66b)
FCF Margin = 6.08% (FCF TTM 2.29b / Revenue TTM 37.65b)
Net Margin = 9.38% (Net Income TTM 3.53b / Revenue TTM 37.65b)
Gross Margin = 30.99% ((Revenue TTM 37.65b - Cost of Revenue TTM 25.98b) / Revenue TTM)
Gross Margin QoQ = 26.81% (prev 32.44%)
Tobins Q-Ratio = 1.31 (Enterprise Value 93.66b / Total Assets 71.36b)
Interest Expense / Debt = 0.10% (Interest Expense 22.0m / Debt 21.93b)
Taxrate = 15.52% (137.0m / 883.0m)
NOPAT = 3.49b (EBIT 4.13b * (1 - 15.52%))
Current Ratio = 0.61 (Total Current Assets 13.15b / Total Current Liabilities 21.51b)
Debt / Equity = 0.84 (Debt 21.93b / totalStockholderEquity, last quarter 26.18b)
Debt / EBITDA = 3.76 (Net Debt 20.57b / EBITDA 5.47b)
Debt / FCF = 8.98 (Net Debt 20.57b / FCF TTM 2.29b)
Total Stockholder Equity = 26.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.95% (Net Income 3.53b / Total Assets 71.36b)
RoE = 13.44% (Net Income TTM 3.53b / Total Stockholder Equity 26.27b)
RoCE = 9.85% (EBIT 4.13b / Capital Employed (Equity 26.27b + L.T.Debt 15.66b))
RoIC = 7.63% (NOPAT 3.49b / Invested Capital 45.69b)
WACC = 5.94% (E(73.10b)/V(95.03b) * Re(7.70%) + D(21.93b)/V(95.03b) * Rd(0.10%) * (1-Tc(0.16)))
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.24%
[DCF Debug] Terminal Value 77.88% ; FCFE base≈2.85b ; Y1≈2.78b ; Y5≈2.79b
Fair Price DCF = 38.41 (DCF Value 49.56b / Shares Outstanding 1.29b; 5y FCF grow -3.84% → 3.0% )
EPS Correlation: -27.65 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 50.90 | Revenue CAGR: 4.23% | SUE: 0.23 | # QB: 0

Additional Sources for MDLZ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle